Evidence map›Paper›PMID 42269072›Full record

ArticleProceedings (Baylor University. Medical Center)2026

Comparing characteristics and outcomes in admissions with pulmonary embolism and inflammatory bowel disease: a national cohort study.

Danzhu Zhao, Aryan Mehta, Zade Bihag, Joseph J Ingrassia, Haleh Vaziri

Abstract readComparative Study
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pulmonary embolism in inflammatory bowel disease: competing risks at the bedside.Proceedings (Baylor University. Medical Center) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Danzhu ZhaoDepartment of Medicine, University of Connecticut, Farmington, Connecticut, USA.
Aryan MehtaDepartment of Medicine, University of Connecticut, Farmington, Connecticut, USA.
Zade BihagDepartment of Medicine, University of Connecticut, Farmington, Connecticut, USA.
Joseph J IngrassiaDivision of Cardiology, Department of Medicine, Heart and Vascular Hospital, Hartford, Connecticut, USA.
Haleh VaziriDivision of Gastroenterology and Hepatology, Department of Medicine, University of Connecticut, Farmington, Connecticut, USA.ORCID 0000-0002-1550-5496

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVenous thromboembolism (VTE) is a known complication of inflammatory bowel disease (IBD) with significant morbidity and mortality. However, outcomes of pulmonary embolism (PE) in patients with IBD remain limited.

methodsUsing the National Inpatient Sample (2016-2021), we identified primary PE admissions and stratified patients by the presence or absence of IBD, ulcerative colitis (UC), and Crohn's disease (CD). Outcomes included in-hospital mortality, complications, and health care utilization.

resultsAmong 1,096,499 PE admissions, 9868 (0.9%) had IBD. Compared with patients without IBD, patients with IBD were younger, more often female, and Caucasian (all

conclusionIn-hospital mortality in PE admissions was similar with and without IBD. The UC cohort had more bleeding complications than the CD cohort without mortality differences. The IBD cohort had higher hospitalization costs than those without IBD despite a similar length of stay.

Indexed as

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesPulmonary EmbolismAdultAgedCohort StudiesFemaleHospitalizationHospital MortalityHumansMaleMiddle AgedRisk FactorsUnited StatesVenous ThromboembolismInflammatory bowel diseasepulmonary embolismtherapyvenous thromboembolism

Identifiers

PMID42269072
PMCPMC13271293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.